相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In pursuit of the triple crown: mechanism-based pharmacodynamic modelling for the optimization of three-drug combinations against KPC-producing Klebsiella pneumoniae
N. J. Onufrak et al.
CLINICAL MICROBIOLOGY AND INFECTION (2020)
Effect of Moxifloxacin plus Pretomanid against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay
Carolina de Miranda Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log Phase, Acid Phase, and Nonreplicating-Persister Phase in an In Vitro Assay
Carolina de Miranda Silva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
The Combination of Fosfomycin plus Meropenem Is Synergistic for Pseudomonas aeruginosa PAO1 in a Hollow-Fiber Infection Model
G. L. Drusano et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity
Justin R. Lenhard et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Sofosbuvir (SOF) Suppresses Ledipasvir (LDV)-resistant Mutants during SOF/LDV Combination Therapy against Genotype 1b Hepatitis C Virus (HCV)
Ashley N. Brown et al.
SCIENTIFIC REPORTS (2017)
An In Vitro Caseum Binding Assay that Predicts Drug Penetration in Tuberculosis Lesions
Jansy P. Sarathy et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2017)
Bactericidal and Sterilizing Activity of a Novel Regimen with Bedaquiline, Pretomanid, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis
Si-Yang Li et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The association between sterilizing activity and drug distribution into tuberculosis lesions
Brendan Prideaux et al.
NATURE MEDICINE (2015)
Preclinical Evaluations To Identify Optimal Linezolid Regimens for Tuberculosis Therapy
Ashley N. Brown et al.
MBIO (2015)
Contribution of the Nitroimidazoles PA-824 and TBA-354 to the Activity of Novel Regimens in Murine Models of Tuberculosis
Rokeya Tasneen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Combination Treatment With Meropenem Plus Levofloxacin Is Synergistic Against Pseudomonas aeruginosa Infection in a Murine Model of Pneumonia
Arnold Louie et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Population Pharmacokinetics of Bedaquiline (TMC207), a Novel Antituberculosis Drug
Sarah C. McLeay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Analysis of Combination Drug Therapy to Develop Regimens with Shortened Duration of Treatment for Tuberculosis
George L. Drusano et al.
PLOS ONE (2014)
Pharmacokinetics and Pharmacodynamics of TMC207 and Its N-Desmethyl Metabolite in a Murine Model of Tuberculosis
Marie-Claude Rouan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Accurate Detection of Outliers and Subpopulations With Pmetrics, a Nonparametric and Parametric Pharmacometric Modeling and Simulation Package for R
Michael N. Neely et al.
THERAPEUTIC DRUG MONITORING (2012)
PA-824 Exhibits Time-Dependent Activity in a Murine Model of Tuberculosis
Zahoor Ahmad et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
G. L. Drusano et al.
MBIO (2010)
Safety, Tolerability, and Pharmacokinetics of PA-824 in Healthy Subjects
Ann M. Ginsberg et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: A new paradigm for optimizing pharmacodynamics to counterselect resistance
Vincent H. Tam et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Moxifloxacin, ofloxacin, sparfloxacin, and ciprofloxacin against Mycobacterium tuberculosis:: Evaluation of in vitro and pharmacodynamic indices that best predict in vivo efficacy
Radha K. Shandil et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
分享论文
